You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc.
The small molecule drugs covered by the patent cited in this case are ⤷  Sign Up and ⤷  Sign Up .

Details for Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2023)

Date Filed Document No. Description Snippet Link To Document
2024-03-22 18 Answer to Complaint United States Patent Nos. 7,094,781 (“the ’781 patent”) and 10,946,015 (“the ’015 patent”) (collectively… be a patent infringement action alleging infringement of United States Patent Nos. 7,094,781 (“the’781…: INVALIDITY OF U.S. PATENT NO. 7,094,781 The claims of the ’781 patent are invalid for failure…AFFIRMATIVE DEFENSE: NONINFRINGEMENT OF U.S. PATENT NO. 7,094,781 Mylan has not infringed, induced…’781 patent”) and 10,946,015 (“the ’015 patent”) pursuant to the patent laws of the United States, 35 External link to document
2024-04-12 20 Amended Complaint United States Patent Nos. 7,094,781 (“the ’781 patent”) and 10,946,015 (“the ’015 patent”) (collectively…781 patent, titled “Sulfamides and Their Use as Endothelin Receptor Antagonists.” The ’781 patent duly… the ’781 patent is attached as Exhibit A. 17. Actelion Ltd owns the ’015 patent, titled “…Pyrimidine-Sulfamide.” The ’015 patent duly and legally issued on March 16, 2021. A copy of the ’015 patent is attached …contentions regarding patent validity, Mylan’s Notice Letter with respect to the ’781 patent does not identify External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.